Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating revenues:        
License revenues $ 500 $ 500
Operating expenses:        
Research and development 1,617 1,210 6,098 3,071
General and administrative 1,044 777 2,725 2,073
Operating loss (2,661) (1,487) (8,823) (4,644)
Other (income) expense:        
Governmental assistance - research incentives (263) (196) (663) (1,046)
Other (income) expense, net 38 39 (20) 61
Change in fair value of warrant liability 39
Total other (income) expense (225) (157) (683) (946)
Loss before income tax expense (2,436) (1,330) (8,140) (3,698)
Income tax expense 12 57 29 74
Net loss (2,448) (1,387) (8,169) (3,772)
Other comprehensive income        
Unrealized (gain) loss on marketable securities 5 (6)
Net loss and comprehensive loss $ (2,453) $ (1,387) $ (8,163) $ (3,772)
Basic and diluted net loss per share (in dollars per share) $ (0.20) $ (0.18) $ (0.68) $ (0.51)
Weighted average shares outstanding – basic and diluted (in shares) 12,006,874 7,836,683 11,981,233 7,406,378